Cathelicidin LL-37 in Health and Diseases of the Oral Cavity

被引:27
|
作者
Tokajuk, Joanna [1 ,2 ]
Deptula, Piotr [1 ]
Piktel, Ewelina [3 ]
Daniluk, Tamara [1 ]
Chmielewska, Sylwia [1 ]
Wollny, Tomasz [4 ]
Wolak, Przemyslaw [5 ]
Fiedoruk, Krzysztof [1 ]
Bucki, Robert [1 ]
机构
[1] Med Univ Bialystok, Dept Med Microbiol & Nanobiomed Engn, Mickiewicza 2C, PL-15222 Bialystok, Poland
[2] Dent & Med Tokajuk, Zelazna 9-7, PL-15297 Bialystok, Poland
[3] Med Univ Bialystok, Independent Lab Nanomed, Mickiewicza 2B, PL-15222 Bialystok, Poland
[4] Holy Cross Oncol Ctr Kielce, Artwinskiego 3, PL-25734 Kielce, Poland
[5] Jan Kochanowski Univ Kielce, Coll Med, Inst Med Sci, IX Wiekow Kielc 19A, PL-25317 Kielce, Poland
关键词
oarl cavity; human cathelicidin; antimicrobial peptides; immunomodulation; ANTIMICROBIAL PEPTIDE LL-37; GINGIVAL CREVICULAR FLUID; PORPHYROMONAS-GINGIVALIS; ANTIBACTERIAL ACTIVITY; GROWTH-FACTOR; SALIVARY CONCENTRATION; EPITHELIAL-CELLS; INNATE IMMUNITY; MYELOID CELLS; CANCER-CELLS;
D O I
10.3390/biomedicines10051086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms for maintaining oral cavity homeostasis are subject to the constant influence of many environmental factors, including various chemicals and microorganisms. Most of them act directly on the oral mucosa, which is the mechanical and immune barrier of the oral cavity, and such interaction might lead to the development of various oral pathologies and systemic diseases. Two important players in maintaining oral health or developing oral pathology are the oral microbiota and various immune molecules that are involved in controlling its quantitative and qualitative composition. The LL-37 peptide is an important molecule that upon release from human cathelicidin (hCAP-18) can directly perform antimicrobial action after insertion into surface structures of microorganisms and immunomodulatory function as an agonist of different cell membrane receptors. Oral LL-37 expression is an important factor in oral homeostasis that maintains the physiological microbiota but is also involved in the development of oral dysbiosis, infectious diseases (including viral, bacterial, and fungal infections), autoimmune diseases, and oral carcinomas. This peptide has also been proposed as a marker of inflammation severity and treatment outcome.
引用
收藏
页数:30
相关论文
共 50 条
  • [41] Human cathelicidin LL-37 rapidly disrupted colonic epithelial integrity
    Kilari, Geeta
    Tran, Jacquelyn
    Blyth, Graham A. D.
    Cobo, Eduardo R.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2025, 1867 (03):
  • [42] Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease
    Kusaka, S.
    Nishida, A.
    Takahashi, K.
    Bamba, S.
    Yasui, H.
    Kawahara, M.
    Inatomi, O.
    Sugimoto, M.
    Andoh, A.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 191 (01): : 96 - 106
  • [43] The expression of B-defensins, cathelicidin (LL-37) in skin tumors
    Park, Y.
    Whang, K.
    Lee, J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2013, 133 : S59 - S59
  • [44] The expression of B-defensins, cathelicidin (LL-37) in skin tumors
    Whang, Kyu Uang
    Oh, Sang Jin
    Choi, Seung Il
    Lee, Sung Yul
    Kim, Ye Seul
    Bae, You In
    Park, Young Lip
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB8 - AB8
  • [45] Neutrophil secondary necrosis is induced by LL-37 derived from cathelicidin
    Zhang, Zhifang
    Cherryholmes, Gregory
    Shively, John E.
    JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (03) : 780 - 788
  • [46] The Human Cathelicidin LL-37, a Defensive Peptide Against Rotavirus Infection
    Hosseini, Zohreh
    Najafi, Mohammad Bagher Habibi
    Yavarmanesh, Masoud
    Ataei-Pirkooh, Angila
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2020, 26 (02) : 911 - 919
  • [47] Efficacy of Cathelicidin LL-37 in an MRSA Wound Infection Mouse Model
    Simonetti, Oriana
    Cirioni, Oscar
    Goteri, Gaia
    Lucarini, Guendalina
    Kamysz, Elzbieta
    Kamysz, Wojciech
    Orlando, Fiorenza
    Rizzetto, Giulio
    Molinelli, Elisa
    Morroni, Gianluca
    Ghiselli, Roberto
    Provinciali, Mauro
    Giacometti, Andrea
    Offidani, Annamaria
    ANTIBIOTICS-BASEL, 2021, 10 (10):
  • [48] Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
    Reinholz, Markus
    Ruzicka, Thomas
    Schauber, Juergen
    ANNALS OF DERMATOLOGY, 2012, 24 (02) : 126 - 135
  • [49] Cathelicidin (LL-37) level in the scalp hair of patients with tinea capitis
    Abdelaal, Nagwa H.
    Rashed, Laila A.
    Ibrahim, Sahar Y.
    Abd El Halim, Mona H.
    Ghoneim, Noha
    Saleh, Noha A.
    Saleh, Marwah A.
    MEDICAL MYCOLOGY, 2017, 55 (07) : 733 - 736
  • [50] Design of Antimicrobial Peptides: Progress Made with Human Cathelicidin LL-37
    Wang, Guangshun
    Narayana, Jayaram Lakshmaiah
    Mishra, Biswajit
    Zhang, Yingxia
    Wang, Fangyu
    Wang, Chunfeng
    Zarena, D.
    Lushnikova, Tamara
    Wang, Xiuqing
    ANTIMICROBIAL PEPTIDES: BASICS FOR CLINICAL APPLICATION, 2019, 1117 : 215 - 240